5th Mar 2019 15:42
LONDON (Alliance News) - KRM22 PLC on Tuesday said Non-Executive Director Jim Oliff has decided to step down from his role on the company's board while he undergoes treatment for cancer.
Oliff said: "It is with deep regret that I must resign from the board of KRM22. I am in the final stages of treatment for cancer which prevents me from giving the time, attention and focus that both management and the shareholders deserve.
"I remain very optimistic that the company is on the right path and that it is providing unique value to the financial services industry."
Shares in the technology and software investment company were untraded at 94.00 pence each.
Related Shares:
Krm22 Plc